-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Fp0aLCzRvzfBKaV1zIryLGyhPs55f2h7XxZ2LsOs42/gv0XWs2F0okfcGZdA9jEx 784Wd7bYeiNJD5lmEQpQVA== 0001082554-05-000007.txt : 20050121 0001082554-05-000007.hdr.sgml : 20050121 20050121201954 ACCESSION NUMBER: 0001082554-05-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050120 FILED AS OF DATE: 20050121 DATE AS OF CHANGE: 20050121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JEFFS ROGER CENTRAL INDEX KEY: 0001231615 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 05542916 BUSINESS ADDRESS: STREET 1: C/O UNITED THERAPEUTICS CORP STREET 2: 1110 SPRING STREET CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS CORP CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2005-01-20 0 0001082554 UNITED THERAPEUTICS CORP UTHR 0001231615 JEFFS ROGER 1 1 0 0 President and COO Common Stock 2005-01-20 2005-01-20 4 M 0 3500 12.69 A 16832 D Common Stock 2005-01-20 2005-01-20 4 S 0 3500 44.34 D 13332 D Employee Stock Options 12.69 2005-01-20 2005-01-20 4 M 0 3500 0 D 2000-05-01 2010-05-01 Common Stock 3500 495506 D The exercise of stock options and the corresponding sale of 3,500 shares (the "Shares") are pursuant to the 10b5-1 Plan adopted by the reporting person on November 11, 2003. All proceeds from the sale of Shares after tax withholding will be applied toward repayment of principal and interest of United Therapeutics' April 2002 loan to the reporting person to purchase his primary residence. /s/ Paul A. Mahon under Power of Attorney 2005-01-21 -----END PRIVACY-ENHANCED MESSAGE-----